Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Finished Goods: 2015-2016

Historic Finished Goods for Cumberland Pharmaceuticals (CPIX) over the last 2 years, with Dec 2016 value amounting to $2.3 million.

  • Cumberland Pharmaceuticals' Finished Goods rose 56.64% to $2.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $2.3 million, marking a year-over-year increase of 56.64%. This contributed to the annual value of $2.3 million for FY2016, which is 56.64% up from last year.
  • Cumberland Pharmaceuticals' Finished Goods amounted to $2.3 million in FY2016, which was up 56.64% from $1.5 million recorded in FY2015.
  • Cumberland Pharmaceuticals' 5-year Finished Goods high stood at $2.3 million for FY2016, and its period low was $1.5 million during FY2015.
  • In the last 2 years, Cumberland Pharmaceuticals' Finished Goods had a median value of $1.9 million in 2015 and averaged $1.9 million.
  • Data for Cumberland Pharmaceuticals' Finished Goods shows a peak YoY soared of 56.64% (in 2016) over the last 5 years.
  • Yearly analysis of 2 years shows Cumberland Pharmaceuticals' Finished Goods stood at $1.5 million in 2015, then soared by 56.64% to $2.3 million in 2016.